GlassScriptPhysician profile
Pankaj K Dhingra
NPI 1639380926
$1,845.16
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $123 · 2021: $374 · 2022: $125 · 2023: $140 · 2024: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $335.33 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $332.66 | 2019-2024 | Breztri |
| Radius Health, INC. | $250.33 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $196.24 | 2020-2021 | |
| Glaxosmithkline, LLC. | $140.20 | 2022-2023 | Benlysta |
| Opko Pharmaceuticals, LLC | $129.17 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.80 | 2023 | Jardiance |
| Vifor Pharma, INC. | $66.36 | 2019 | |
| Mallinckrodt Enterprises LLC | $60.92 | 2019 | |
| Lundbeck LLC | $39.79 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $32.61 | 2019-2021 | |
| Fresenius USA Marketing, INC. | $29.35 | 2019 | |
| Horizon Therapeutics Plc | $23.32 | 2019-2020 | |
| Pfizer INC. | $22.98 | 2024 | |
| Alexion Pharmaceuticals, INC. | $16.37 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $14.51 | 2019 | |
| Shire North American Group INC | $14.22 | 2019 | |
| Daiichi Sankyo INC. | $13.38 | 2020 | |
| Travere Therapeutics, INC. | $2.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Dhingra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.